Online Store

 

Stopping the Syndemic: Successful Strategies for Managing Glucose and Promoting Weight Loss

This interactive symposium, with charismatic expert clinicians presenting information in a conversational style on the Med Table Talk™ platform, will focus on overcoming clinical inertia, weight loss as a treatment target, why it is important to understand the newest data on the role and effects of incretins, and shared decision making for sustained weight loss and glucose management. 

Member Price
$0.00
Non-Member Price
$0.00

  • Description
  • Faculty
  • Disclosures
  • Accreditation
  • Pricing
  • Credits

90-minute Program
Effective dates for CE credit: 10/21/2022– 10/21/2024

Description

The national prevalence of T2D has grown in parallel with rates of obesity, and this silent “twindemic” represents an alarming health crisis in all communities. Collaborative interprofessional care with Diabetes Care and Education Specialists (DCES) is essential to improve patient awareness and health literacy. This interactive symposium, with charismatic expert clinicians presenting information in a conversational style on the Med Table Talk™ platform, will focus on overcoming clinical inertia, weight loss as a treatment target, why it is important to understand the newest data on the role and effects of incretins, and shared decision making for sustained weight loss and glucose management. Both prescribers and non-prescribers will be given strategies to help their patients from all backgrounds and life experiences reach their glycemic and weight-loss goals.

Learning Outcome

The learner will report an increased understanding of strategies to properly adjust treatments for higher weight individuals to lose weight and manage glucose while considering the pathophysiology and diversity of each patient when selecting safe and effective therapies such as GLP-1 RAs and Dual GLP-1/GIP RAs.

Learning Objectives

At the end of this presentation, participants will be able to:
-- Know the best practice guidelines to align patients with the appropriate therapies to address weight and glucose management.
-- Address barriers such as access to novel therapeutics, and how to assess and minimize the impact of social determinants of health as much as possible.
-- How to incorporate these interventions and therapeutics in an inter-professional environment using shared decision making by the team.

Activity Type

This recording of a live presentation is an application-based learning activity.

Learning Format

Enduring Material

Intended Audience

ADCES Webinars are designed for individual or groups of diabetes care and education specialists, including nurses, dietitians, dietetic technicians, pharmacists, pharmacy technicians, nurse practitioners, clinical nurse specialists, physicians, PAs, social workers, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.

Access Period

You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).

Originally presented on: 8/13/2022
Expiration date: 10/21/2024

Speakers

Kimberly F. Ellis, MSN, FNP-C, CDCES
Family Nurse Practitioner and Certified Diabetes Care & Education Specialist
Ellis Diabetes Education and Consulting
Cedar Hill, TX

Kathy B. Doane, PharmD, RPh, CMTM, BC-ADM, CDCES, RDN
Clinical Pharmacist Specialist and Diabetes Educator
Caring Health Center
East Longmeadow, MA

Adrienne Maye, RN, BSN, CDCES
Owner and Certified Diabetes Care and Education Specialist
Moving Forward with Diabetes Management, LLC
Dallas, GA

Faculty Disclosures

Inaccordance with Joint Accreditation criteria and the ACCME’s Standards forIntegrity and Independence in Accredited Continuing Education, the Associationof Diabetes Care & Education Specialists (ADCES) must ensure that anyone ina position to control the content of the educational activity (planners andspeakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.

Joint Accreditation/ACCME also requires that ADCES mitigate any reported conflict and eliminate the potential for bias during the educational activity. The disclosure information is intended to identify any ineligible relationships and allow learners to form their own judgments. However, if you perceive a bias during an activity, please report it on the evaluation.

Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:

Speakers

No speakers involved in this activity have any conflicts to disclose.

Planners

Marissa Grossman, Education Manager, Medical Learning Insititute, Inc., Conflict(s): Stabiliz Ortopaedics (Stock)
Jodi Lavin-Tompkins, MSN, RN, CDCES, BC-ADM, Director of Accreditation/Content Development, ADCES, Conflict(s): Gilead Sciences, Regeneron Pharma (Stock, relationship ended)
Michael R. Page, PharmD, RPh, Medical Director, Med Learning Group, Conflict(s): American Medical Communications; BioCentric, Inc (Consultant)

Disclosure and Mitigation of Relevant Conflicts of Interest

All identified relevant conflicts of interest have been mitigated.

The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

Joint Providership

Medical Learning Institute

Financial Support

This activity is supported by an educational grant from Lilly.

Accreditation

In support of improving patient care, this activity has been planned by Medical Learning Institute, Inc. and the Association of Diabetes Care & Education Specialists. Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 Accreditation Council for Pharmacy Education (ACPE)

The Universal Activity Number is JA4008258-0000-22-320-H01-P This knowledge-based activity has been approved for 1.5 contact hour(s).
This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor.

 American Medical Association (AMA)

Association of Diabetes Care & Education Specialists designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 American Nurses Credentialing Center (ANCC)

Association of Diabetes Care & Education Specialists designates this activity for a maximum of 1.5 ANCC contact hour(s). This activity discusses 0.5 contact hour(s) of pharmacotherapeutic content.
The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 1.5 contact hour(s).

American Academy of PAs (AAPA)

The Association of Diabetes Care & Education Specialists has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credit(s). Approval is valid until 1/26/23. PAs should only claim credit commensurate with the extent of their participation.

Commission on Dietetic Registration (CDR)

CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education unit(s) (CPEU) for completion of this activity.
Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Sphere and Competency selection is at the learner’s discretion.

Association of Social Work Boards (ASWB)

As a Jointly Accredited Organization, the Association of Diabetes Care & Education Specialists is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. The Association of Diabetes Care & Education Specialists maintains responsibility for this course. Social workers completing this course receive 1.5continuing education credits.

Successful Completion

To receive a Statement of Credit you must participate in the full activity and complete an evaluation.

Certified Diabetes Care and Education Specialists

To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers ( www.cbdce.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.

Board Certified Advanced Diabetes Management (BC-ADM)

ADCES is the administering body for the Advanced Diabetes Management credentials. Continuing education programs offered by ADCES can be used toward fulfilling BC-ADM Certification and recertification requirements.

Other Health Professionals

It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or recertification for their discipline.

Pricing

Members: $0.00
Non-Members: $0.00

Access Period

You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).

Originally presented on: 8/13/2022
Expiration date: 10/21/2024

Apply: 1.50